NCT06508814 Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
| NCT ID | NCT06508814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tennessee |
| Condition | Post Operative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-06-10 |
| Primary Completion | 2025-06-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-06-10 with a primary completion date of 2025-06-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the effect of decreased insufflation pressure on postoperative pain, analgesic use, and surgical safety and feasibility for laparoscopic hysterectomy.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 to 80 * BMI 55.0 or less * Laparoscopic hysterectomy surgery planned Exclusion Criteria: * Women younger than 18 or older than 80 years of age * BMI over 55.0 * Laparoscopic hysterectomy surgery not planned
Frequently Asked Questions
Who can join the NCT06508814 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06508814 currently recruiting?
Yes, NCT06508814 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Tennessee to inquire about joining.
Where is the NCT06508814 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT06508814 clinical trial?
NCT06508814 is sponsored by University of Tennessee. The trial plans to enroll 100 participants.